中文 | English
Return
Total: 6 , 1/1
Show Home Prev Next End page: GO
Author:( Yanfa XU)

1.CLINICAL ANALYSIS OF 46 CASES WITH LIPOSARCOMA

Yanfa XU ; Zhengxiang DANG ;

Journal of Xi'an Jiaotong University(Medical Sciences) 1982;0(04):-

2.THE EXPRESSION AND CLINICAL SIGNIFICANCE OF P21 (WAF1/CIP1)AND CYCLIN D1 PROTEIN IN COLORECTAL CARCINOMA

Liahui LEI ; Yanfa XU ; Wei SHENG

Journal of Pharmaceutical Analysis 2000;12(2):160-162,167

3.Pathogens of Catheter-related Bloodstream Infection

Yaping XU ; Guang ZHOU ; Yanfa ZHONG ; Yengfang WANG ; Xiuju ZHANG

Chinese Journal of Nosocomiology 2006;0(09):-

4.THE EXPRESSION OF P53 PROTEIN AND P21WAFl/cipl/sdil IN GASTRIC CARCINOMA

Junkai DU ; Yanfa XU ; Zhaozhen ZHONG ; Qian WANG

Journal of Pharmaceutical Analysis 2001;13(2):148-151,163

5.Risk factor analysis of postoperative complications in colorectal cancer patients

Xinhua LIAO ; Lei ZHANG ; Yanfa XU ; Xiongwei HUO ; Xiangming CHE ; Na LI

Journal of Xi'an Jiaotong University(Medical Sciences) 1981;0(03):-

6.miR-185-5p alleviates the inflammatory response of acute gouty arthritis by inhibiting of IL-1β.

Nan HOU ; Xianghui MA ; Wei ZHOU ; Min YUAN ; Liming XU ; Huanxia SUN ; Yifan LIU ; Lining LIU ; Yanjun SHI ; Chunxian LI ; Yanfa FU

Chinese Journal of Cellular and Molecular Immunology 2024;40(1):51-57

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 6 , 1/1 Show Home Prev Next End page: GO